ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
114 hedge funds and large institutions have $294M invested in Achillion Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+4
Holders Change %
+3.64%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
34
Reduced
30
Closed
10
Calls
$291K
Puts
$154K
Net Calls
+$137K
Net Calls Change
-$187K
Top Buyers
| 1 |
Nuveen Asset Management
Chicago,
Illinois
|
+$7.81M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.89M |
| 3 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
+$3.38M |
| 4 |
Morgan Stanley
New York
|
+$2.04M |
| 5 |
Renaissance Technologies
New York
|
+$1.95M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$7.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.61M |
| 3 |
Millennium Management
New York
|
-$2.19M |
| 4 |
Axa
Paris,
France
|
-$1.67M |
| 5 |
Goldman Sachs
New York
|
-$1.57M |
